Bruker Corporation (BRKR) – What Are Analysts Saying About This Stock?

Bruker Corporation (NASDAQ:BRKR) has been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, five have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $60.57.

Several brokerages have commented on BRKR. Citigroup raised their price objective on Bruker from $53.00 to $64.00 and gave the company a “hold” rating in a report on Thursday, November 5th. Zacks Research lowered Bruker from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 2nd. TD Cowen lifted their price target on shares of Bruker from $60.00 to $62.00 and gave the company a “hold” rating in a research note on Tuesday, October 13th. Guggenheim lifted their price target on shares of Bruker from $70.00 to $72.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Finally, JPMorgan Chase & Co. lowered shares of Bruker from an “overweight” rating to a “neutral” rating and set a $60.00 price target for the company. in a report on Wednesday, October 14th.

Insider Activity

In other news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total transaction of $105,740.00. Following the completion of the sale, the vice president owned 134,806 shares of the company’s stock, valued at $7,127,193.22. The trade was a 1.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 27.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BRKR. Essential Partners LLC purchased a new stake in Bruker during the 1st quarter worth approximately $36,000. Global Retirement Partners LLC purchased a new position in shares of Bruker in the second quarter valued at approximately $38,000. Provenance Wealth Advisors LLC acquired a new stake in shares of Bruker in the third quarter worth approximately $52,000. EverSource Wealth Advisors LLC boosted its stake in shares of Bruker by 532.9% in the first quarter. EverSource Wealth Advisors LLC now owns 1,500 shares of the medical research company’s stock worth $54,000 after acquiring an additional 1,263 shares during the last quarter. Finally, Root Financial Partners LLC acquired a new stake in shares of Bruker in the third quarter worth approximately $57,000. 79.52% of the stock is owned by hedge funds and other institutional investors.

Bruker Trading Up 8.5%

Shares of Bruker stock opened at $66.54 on Tuesday. The firm has a 50-day simple moving average of $59.20 and a two-hundred day simple moving average of $50.66. The company has a market cap of $10.14 billion, a P/E ratio of -60.49, a price-to-earnings-growth ratio of 1.95 and a beta of 1.26. Bruker has a fifty-two week low of $32.37 and a fifty-two week high of $68.98. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.84.

Bruker (NASDAQ:BRKR) last posted its earnings results on Wednesday, November 4th. The medical research company reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.14. Bruker had a positive return on equity of 13.76% and a negative net margin of 3.82%. The firm had revenue of $874.00 million for the quarter, compared to analysts’ expectations of $865.16 million. During the same period last year, the firm earned $0.45 EPS. The company’s quarterly revenue was up 1.6% on a year-over-year basis. As a group, equities analysts predict that Bruker will post 2.13 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 7th. Stockholders of record on Monday, September 21st were given a $0.05 dividend. The ex-dividend date was Monday, September 21st. This represents a $0.20 annualized dividend and a dividend yield of 0.3%. Bruker’s dividend payout ratio (DPR) is -18.18%.

Bruker Company Profile

Bruker develops and manufactures scientific instruments and analytical technologies used to study biological, chemical and physical materials. Its products support research and testing in areas including life sciences, pharmaceuticals, biotechnology, materials science, chemicals and clinical diagnostics.

The company’s offerings include nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray and microscopy instruments, and infrared and Raman spectroscopy solutions.